Divide all glomerulonephrits into nephrotic and nephritic

Here's a quick overview before I pull the full textbook detail:
Nephrotic syndrome = massive proteinuria, hypoalbuminemia, edema, hyperlipidemia. Podocyte/basement membrane injury is the core mechanism.
Nephritic syndrome = hematuria, RBC casts, hypertension, oliguria, mild-moderate proteinuria. Inflammatory/proliferative injury with glomerular hypercellularity.
Quick classification:
  • Nephrotic: MCD, FSGS, Membranous, Diabetic nephropathy, Amyloidosis
  • Nephritic: Post-streptococcal GN, IgA nephropathy, MPGN, Lupus nephritis, Anti-GBM disease, ANCA vasculitis
Searching sources...
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive material. Let me read the nephrotic section more fully for FSGS, membranous GN, and MPGN details.
Reading File
I have enough comprehensive material to construct a thorough, well-referenced answer. Let me also look at the summary table referenced in the textbook.
Reading File
I now have all the material needed for a comprehensive, textbook-backed answer. Let me also pull relevant histology images.
Searching Images

glomerulonephritis nephrotic nephritic classification comparison table

A comparison chart of mass spectra illustrating differentially expressed urinary protein profiles in children with primary nephrotic syndrome (PNS). The image displays six spectral plots categorized into three groups: Steroid-sensitive (SSNS), Steroid-resistant (SRNS), and a healthy Control group. The x-axis represents the mass-to-charge ratio (m/e) ranging from 5,000 to 20,000, while the y-axis indicates protein intensity. The Steroid-sensitive group shows a dominant diagnostic peak at m/e 6703. In contrast, the Steroid-resistant group is characterized by a distinct proteomic signature with three prominent peaks at m/e 7212, 11820, and 14356. The Control group exhibits a relatively flat baseline with negligible peak expression at these specific values. This diagnostic visual serves to identify potential protein biomarkers for differentiating between steroid treatment responses in pediatric nephrology, facilitating the classification of steroid-resistant vs. steroid-sensitive nephrotic syndrome based on urinary proteomic analysis.

A comparison chart of mass spectra illustrating differentially expressed urinary protein profiles in children with primary nephrotic syndrome (PNS). The image displays six spectral plots categorized into three groups: Steroid-sensitive (SSNS), Steroid-resistant (SRNS), and a healthy Control group. The x-axis represents the mass-to-charge ratio (m/e) ranging from 5,000 to 20,000, while the y-axis indicates protein intensity. The Steroid-sensitive group shows a dominant diagnostic peak at m/e 6703. In contrast, the Steroid-resistant group is characterized by a distinct proteomic signature with three prominent peaks at m/e 7212, 11820, and 14356. The Control group exhibits a relatively flat baseline with negligible peak expression at these specific values. This diagnostic visual serves to identify potential protein biomarkers for differentiating between steroid treatment responses in pediatric nephrology, facilitating the classification of steroid-resistant vs. steroid-sensitive nephrotic syndrome based on urinary proteomic analysis.

A comparison chart and diagnostic image summary detailing a dataset for automated respiratory disease classification. The table is divided into two primary categories: 'Healthy' (Class Label 1) and 'COVID-19 infected' (Class Label 2), each containing 94 images for a total of 188 chest X-rays. The 'Samples of the Dataset' column provides a side-by-side visual comparison of posterior-anterior (PA) chest radiographs. The 'Healthy' images demonstrate clear lung fields with distinct costophrenic angles and normal bronchovascular markings. In contrast, the 'COVID-19 infected' samples exhibit characteristic radiological abnormalities, including increased pulmonary opacity, hazy ground-glass opacities, and patchy consolidation across the lung parenchyma, which are hallmark signs of viral pneumonia. This visual representation serves to illustrate the feature differences utilized in machine learning models for detecting COVID-19 manifestations in clinical imaging.

A comparison chart and diagnostic image summary detailing a dataset for automated respiratory disease classification. The table is divided into two primary categories: 'Healthy' (Class Label 1) and 'COVID-19 infected' (Class Label 2), each containing 94 images for a total of 188 chest X-rays. The 'Samples of the Dataset' column provides a side-by-side visual comparison of posterior-anterior (PA) chest radiographs. The 'Healthy' images demonstrate clear lung fields with distinct costophrenic angles and normal bronchovascular markings. In contrast, the 'COVID-19 infected' samples exhibit characteristic radiological abnormalities, including increased pulmonary opacity, hazy ground-glass opacities, and patchy consolidation across the lung parenchyma, which are hallmark signs of viral pneumonia. This visual representation serves to illustrate the feature differences utilized in machine learning models for detecting COVID-19 manifestations in clinical imaging.

A composite clinical comparison chart showing CT scan images and classification data for proximal junctional dens fractures in six patients (Pt 1–6). The table is organized into five columns: sagittal imaging, coronal imaging, pars fracture status, fracture type, and treatment (Trtmt). The sagittal and coronal CT slices illustrate various C2 odontoid and body fracture morphologies, including some with pre-existing posterior spinal instrumentation. The 'Pars Fracture' column uses both text and focused CT images to indicate the presence or absence of a C2 pars fracture. The 'Type' column categorizes injuries according to a classification system (Type II, IIA, and III), while the 'Trtmt' column details clinical management, such as non-operative care (Nonop) or surgical extension to C1 or the occiput, often following non-operative failure. This visual resource serves as an educational tool for neuroradiology and orthopedic spine surgery, demonstrating the relationship between fracture morphology, classification, and management strategies in the context of adult spinal deformity.

A composite clinical comparison chart showing CT scan images and classification data for proximal junctional dens fractures in six patients (Pt 1–6). The table is organized into five columns: sagittal imaging, coronal imaging, pars fracture status, fracture type, and treatment (Trtmt). The sagittal and coronal CT slices illustrate various C2 odontoid and body fracture morphologies, including some with pre-existing posterior spinal instrumentation. The 'Pars Fracture' column uses both text and focused CT images to indicate the presence or absence of a C2 pars fracture. The 'Type' column categorizes injuries according to a classification system (Type II, IIA, and III), while the 'Trtmt' column details clinical management, such as non-operative care (Nonop) or surgical extension to C1 or the occiput, often following non-operative failure. This visual resource serves as an educational tool for neuroradiology and orthopedic spine surgery, demonstrating the relationship between fracture morphology, classification, and management strategies in the context of adult spinal deformity.

I now have all the textbook content needed. Here is the comprehensive, fully referenced classification:

Glomerulonephritis: Nephrotic vs. Nephritic Classification

The Core Distinction

Nephrotic syndrome arises from podocyte/basement membrane injury that increases glomerular permeability to proteins. Hallmarks: heavy proteinuria (>3.5 g/day), hypoalbuminemia, generalized edema, hyperlipidemia, lipiduria. GFR is usually preserved early.
Nephritic syndrome arises from inflammatory, proliferative injury to the glomerular capillary walls. Hallmarks: hematuria with RBC casts, oliguria, azotemia, hypertension, and mild-to-moderate (subnephrotic) proteinuria. The inflammatory reaction injures capillary walls (allowing blood into the urine) and reduces GFR.
As stated in Robbins Basic Pathology: "Glomerular diseases presenting with a nephritic syndrome are characterized by inflammation in the glomeruli... the nephritic syndrome is the typical clinical presentation of most proliferative types of GN."

NEPHROTIC SYNDROME - Primary GN Causes

1. Minimal Change Disease (MCD)

  • Most common nephrotic syndrome in children (peak age 1-7 years)
  • Glomeruli appear normal on light microscopy - no immune deposits on immunofluorescence
  • EM: diffuse effacement (fusion) of podocyte foot processes
  • Selective proteinuria (mainly albumin)
  • Pathogenesis: circulating factors injure podocytes; possible antibodies against slit diaphragm proteins
  • Excellent steroid response in children (>90%); slower and more relapsing in adults
  • Robbins Basic Pathology, p. 504-505

2. Focal Segmental Glomerulosclerosis (FSGS)

  • Sclerosis affects some glomeruli (focal) and only part of each affected glomerulus (segmental)
  • Most common primary GN progressing to end-stage renal disease in the US
  • Forms: primary (idiopathic, ~30% of adult nephrotic syndrome), secondary (HIV, heroin, obesity, nephron loss, genetic mutations in nephrin/podocin)
  • Proteinuria is non-selective; poor steroid response
  • Recurrence after transplant suggests a circulating permeability factor
  • Robbins Basic Pathology, p. 505-507

3. Membranous Nephropathy (MGN)

  • Leading cause of nephrotic syndrome in middle-aged adults
  • Mechanism: in situ immune complex formation - antibodies (most often anti-PLA2R antibody in primary form) bind to podocyte surface antigens
  • LM: diffuse thickening of the GBM; EM: subepithelial "spike and dome" deposits
  • IF: granular IgG and C3 along capillary loops
  • Secondary causes: SLE, HBV/HCV, malignancy (lung, colon), drugs (gold, penicillamine)
  • ~30-40% progress to renal failure over decades
  • Robbins Basic Pathology, p. 507-508

4. Membranoproliferative GN (MPGN)

  • Characterized by GBM thickening AND mesangial hypercellularity ("tram-track" double contour on LM)
  • Type I: immune complex-mediated (HCV, SLE, cryoglobulinemia) - subendothelial deposits
  • Type II (Dense Deposit Disease): dysregulated alternative complement pathway (C3 nephritic factor); intramembranous deposits
  • Clinical presentation: can be either nephrotic or nephritic, making it the classic "overlap" disease
  • Progressive course; poor prognosis without treatment
  • Robbins Basic Pathology, p. 508

5. C3 Glomerulopathy

  • Subset of MPGN characterized by dysregulated complement activation (C3 deposits with little/no immunoglobulin)
  • Includes Dense Deposit Disease (MPGN type II)
  • Caused by C3 nephritic factor, CFH mutations, or other complement regulatory defects

Secondary Causes of Nephrotic Syndrome (not primary GN)

ConditionMechanism
Diabetic nephropathyMesangial expansion, GBM thickening (Kimmelstiel-Wilson nodules); most common cause of CKD in the US
AmyloidosisAmyloid fibrils deposited in mesangium and capillary walls; Congo red positive
Lupus nephritis (Class V - membranous)Immune complex deposition on subepithelial aspect

NEPHRITIC SYNDROME - Primary GN Causes

1. Acute Postinfectious (Post-Streptococcal) GN

  • Classic cause: nephritogenic strains of Group A beta-hemolytic streptococci (pharynx or skin); 1-4 weeks after infection
  • Also: staphylococcal, pneumococcal, HBV, HCV, mumps
  • Mechanism: glomerular deposition of immune complexes (streptococcal antigens + antibodies) → complement activation → neutrophilic inflammation
  • LM: diffuse hypercellularity (endothelial and mesangial proliferation + neutrophil infiltration)
  • EM: subepithelial "humps" (electron-dense deposits)
  • IF: granular IgG and C3 ("starry sky" pattern)
  • Clinical: hematuria, oliguria, hypertension, mild proteinuria; hypocomplementemia (low C3)
  • Prognosis: excellent in children (>95% recover); more guarded in adults
  • Robbins Basic Pathology, p. 509-510

2. Rapidly Progressive (Crescentic) GN (RPGN)

  • Most severe form of nephritic syndrome - renal failure in weeks to months if untreated
  • Crescents = parietal epithelial cell proliferation + monocyte/macrophage migration filling Bowman's space
  • Three immunopathologic types:
    • Type I (Anti-GBM, ~20%): Linear IgG on IF; Goodpasture syndrome if pulmonary hemorrhage co-exists
    • Type II (Immune complex, ~25%): Granular IF; secondary to post-infectious GN, lupus, IgA nephropathy
    • Type III (Pauci-immune, ~55%): No/scanty IF; ANCA-positive (MPO or PR3); associated with GPA/MPA
  • Treatment: immunosuppression (steroids + cyclophosphamide) ± plasmapheresis
  • Robbins Basic Pathology, p. 510-511

3. IgA Nephropathy (Berger's Disease)

  • Most common primary GN worldwide
  • Mechanism: poorly glycosylated IgA1 complexes (IgA + anti-IgA IgG) deposit in the mesangium → complement activation
  • Triggered or worsened by mucosal infections (respiratory, GI) - "synpharyngitic" hematuria
  • LM: mesangial widening and hypercellularity
  • IF: dominant mesangial IgA deposits (C3 + properdin by alternative pathway)
  • Clinical: recurrent episodes of gross hematuria (often concurrent with URIs), persistent microscopic hematuria; nephrotic syndrome in <10%
  • Course: 25-50% reach ESRD over 20 years
  • Robbins Basic Pathology, p. 512-513

4. Lupus Nephritis (Proliferative Classes)

  • Classes III (focal) and IV (diffuse) present as nephritic syndrome with sub/nephrotic range proteinuria
  • Class IV most severe: diffuse proliferative GN with "wire-loop" capillary changes on LM
  • "Full-house" immunofluorescence (IgG, IgA, IgM, C3, C1q)
  • Hypocomplementemia (both C3 and C4 low - classical pathway activation)
  • Class V (membranous lupus) presents as nephrotic syndrome
  • Robbins Basic Pathology, p. 511-512

5. Anti-GBM (Goodpasture) Disease

  • Autoantibodies to the NC1 domain of the α3 chain of type IV collagen → linear IgG on GBM
  • If lung involvement: alveolar hemorrhage = Goodpasture syndrome
  • Isolated renal involvement = anti-GBM GN
  • Clinically presents as RPGN
  • Robbins Basic Pathology, p. 510

Summary Comparison Table

FeatureNephroticNephritic
Proteinuria>3.5 g/day (massive)<3.5 g/day (mild-moderate)
HematuriaAbsent or mildProminent; RBC casts
EdemaMassive (periorbital, dependent)Mild (due to fluid retention)
HypertensionAbsent or mildCommon
AzotemiaAbsent earlyPresent (oliguria)
GFRNormal earlyReduced
Core mechanismPodocyte/BM injury → protein leakInflammatory proliferation → capillary wall damage
HistologyPodocyte foot process effacement; no proliferationHypercellularity, crescents, inflammatory infiltrate

Diseases That Can Cause Both

Some GN present with mixed/overlap features:
  • MPGN - often mixed nephrotic-nephritic
  • Lupus nephritis - Class III/IV (nephritic) vs. Class V (nephrotic)
  • IgA nephropathy - usually nephritic, but can rarely be nephrotic
  • RPGN - nephritic with occasional nephrotic-range proteinuria

Sources: Robbins & Kumar Basic Pathology, 10th ed.; Robbins, Cotran & Kumar Pathologic Basis of Disease, 10th ed.

Lumpy dumpy deposit glomerulonephrits in membrnous

The "lumpy bumpy" pattern refers to the granular immunofluorescence seen in immune complex diseases. In membranous nephropathy, subepithelial immune complex deposits create this classic granular (lumpy-bumpy) pattern on IF - distinct from the linear pattern of anti-GBM disease.
Searching sources...
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Now let me fetch the key IF images for visual illustration.
Loading Image
Loading Image
Loading Image
Excellent - I have the images and complete textbook content. Here is the full answer:

"Lumpy-Bumpy" Deposits in Glomerulonephritis

What the Term Means

"Lumpy-bumpy" (also written "lumpy-dumpy") is a descriptive term used by pathologists for the appearance of immune complex deposits on immunofluorescence (IF) microscopy. The deposits appear as irregular, discontinuous, granular clumps scattered along the glomerular capillary walls and/or mesangium - resembling lumps or bumps rather than a smooth continuous line.
As stated directly in Robbins Basic Pathology: "By immunofluorescence microscopy, these deposits appear granular, to which some pathologists give the rather picturesque description of 'lumpy-bumpy'." - Robbins & Kumar Basic Pathology, p. 502

Why Deposits Are Granular (The Mechanism)

The pattern results from immune complex deposition - either:
  1. Circulating immune complexes that deposit in the GBM (subendothelial or subepithelial)
  2. In situ immune complex formation - antibodies binding to planted or intrinsic antigens in the GBM in a patchy distribution
In both cases, the complexes are deposited in discrete, irregular foci rather than uniformly along the membrane - hence the granular/lumpy appearance.
Mechanisms of glomerular injury showing circulating complexes (granular IF) vs. anti-GBM antibodies (linear IF)
Fig: Circulating or in situ immune complexes (A, B) produce granular "lumpy-bumpy" IF; anti-GBM antibodies (C) produce a linear pattern - Robbins Basic Pathology

Lumpy-Bumpy in Membranous Nephropathy Specifically

Membranous nephropathy (MGN) is the classic example of in situ immune complex formation - and it does produce a granular/lumpy-bumpy pattern, but with an important distinction: the granules are fine and uniform along the outer (subepithelial) aspect of ALL capillary walls.

IF Appearance in Membranous Nephropathy

  • Pattern: Diffuse, finely granular deposits of IgG along the outer surface of all capillary walls
  • Distribution: Global and uniform - every capillary loop in every glomerulus is involved
  • Staining: IgG (dominant, especially IgG4 in primary MN) + C3
  • In primary MN: antibodies target PLA2R (phospholipase A2 receptor) on podocytes; PLA2R staining colocalizes with IgG in a similar finely granular distribution
IF in Membranous Nephropathy: (A) finely granular IgG along capillary walls; (B) PLA2R staining in same distribution
Fig 21.5: IF in Membranous Nephropathy - diffuse finely granular IgG deposits along outer surface of ALL capillary walls - Comprehensive Clinical Nephrology, 7th Ed.

Granular vs. Linear: The Critical Comparison

FeatureGranular (Lumpy-Bumpy)Linear
MechanismImmune complex deposition (circulating or in situ)Anti-GBM antibody binding continuously throughout GBM
IF appearanceIrregular clumps / granulesSmooth, continuous ribbon along capillary wall
DiseasesMGN, post-streptococcal GN, lupus nephritis, IgA nephropathy, MPGNAnti-GBM disease (Goodpasture syndrome)

The Subtlety: Coarse vs. Fine Granularity

Not all granular patterns look the same. The textbook explicitly notes this distinction:
Coarse granularFine granular
Seen inPost-streptococcal GN ("lumpy-bumpy" in the classical sense)Membranous nephropathy
LocationCapillary walls + mesangiumExclusively capillary walls (subepithelial)
StainingIntense C3 >> IgGIgG (dominant) + C3
The coarse "lumpy-bumpy" from post-streptococcal GN reflects large subepithelial "humps" (seen on EM), while membranous nephropathy has smaller, more evenly distributed subepithelial deposits that appear as a finer granular pattern. Brenner & Rector's The Kidney explicitly states: "Compare this to the finely granular capillary wall staining of membranous nephropathy" when contrasting it with the coarse granular pattern of PSGN.
Coarse granular C3 staining in poststreptococcal GN - compare with the fine granular pattern of membranous nephropathy
Fig: Coarse granular C3 staining in acute PSGN - Brenner & Rector's The Kidney

Summary

  • "Lumpy-bumpy" = granular IF pattern = immune complex disease (not anti-GBM)
  • Membranous nephropathy produces this pattern as finely granular IgG deposits along the outer (subepithelial) capillary wall surface
  • The mechanism is in situ immune complex formation: anti-PLA2R antibodies + podocyte antigen → subepithelial deposits
  • Post-streptococcal GN produces a coarser lumpy-bumpy pattern because the immune complex humps are larger and more irregularly distributed
  • The lumpy-bumpy pattern contrasts sharply with the smooth linear pattern of anti-GBM (Goodpasture) disease
This is a shared conversation. Sign in to Orris to start your own chat.